Regeneron Pharmaceuticals (REGN) Analyst & Key Data

Analyst Consensus

Buy65 analysts

Buy

Updated Sep 12, 2026

Total Analysts65

Buy

34

Hold

15

Ratings

Updated Sep 12, 2026

Overall Rating

A

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$781.49

Median Target+4.09%

$813.45

Potential upside vs current price

DCF Value+149.94%

$1,953.26

Potential upside vs current price

Current Stock Price

$781.49

Median Target+4.09%

$813.45

Potential upside vs current price

DCF Value+149.94%

$1,953.26

Potential upside vs current price

Analyst Consensus

Buy65 analysts

Buy

Updated Sep 12, 2026

Total Analysts65

Buy

34

Hold

15

Ratings

Updated Sep 12, 2026

Overall Rating

A

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$781.49

Median Target+4.09%

$813.45

Potential upside vs current price

DCF Value+149.94%

$1,953.26

Potential upside vs current price

Current Stock Price

$781.49

Median Target+4.09%

$813.45

Potential upside vs current price

DCF Value+149.94%

$1,953.26

Potential upside vs current price

Regeneron Pharmaceuticals, Inc.